---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-043324"
form_type: "8-K"
ticker: "MRAI"
cik: "0001844392"
company_name: "Marpai, Inc."
filed_at: "2025-05-14T23:59:59+00:00"
generated_at: "2026-05-21T10:03:10.637890+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Marpai Q1 2025 revenue $5.4M down 27% YoY; operating loss narrows 45% to $2.3M

## Summary
- Net revenue $5.4M, down $2.0M (27%) vs Q1 2024; operating expenses cut 33% to $7.7M.
- Operating loss improved 45% to $2.3M; net loss $3.1M improved 29% vs prior year.
- EPS of ($0.21), improvement of $0.25 per share year over year.
- Unrestricted cash $0.7M at quarter end; CEO targets profitability and positive cash flow by end of 2025.
- Key initiatives: launch of Healthcare Management tool with Empara, MarpaiRx advancements, new COO Dallas Scrip onboarded.

## SEC filing metadata
- accession: 0001213900-25-043324
- form_type: 8-K
- ticker: MRAI
- cik: 0001844392
- company_name: Marpai, Inc.
- filed_at: 2025-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844392/000121390025043324/0001213900-25-043324-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844392/000121390025043324/ea0242151-8k_marpai.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-043324
- JSON: https://secwatch.observer/filing/0001213900-25-043324.json
- Plain text: https://secwatch.observer/filing/0001213900-25-043324.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.